Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Arko Corp. (ARKO) vs BridgeBio Pharma Inc (BBIO) Price & Performance

Arko Corp.Trade
BridgeBio Pharma IncTrade

Price performance (Past 24H)

Key statistics

Arko Corp. vs BridgeBio Pharma Inc — how do they compare? Arko Corp. trades at $4.33 (market cap $493.06M), while BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B). The key difference: BridgeBio Pharma Inc is far larger — about 33.2× Arko Corp.'s market cap, and Arko Corp. pays a 2.73% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.

ARKOBBIO
Market Cap
$493.06M$16.36B
Sector
Consumer CyclicalHealth
52-Week High
$8.64$90.17
52-Week Low
$3.82$47.29
Enterprise Value
$2.67B$18.14B
Dividend Yield
2.73%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Arko Corp.

ARKO Corp operates as a holding company. The company, through its subsidiaries, owns and operates convenience stores in the United States. Some of its regional store brands include Stop, Admiral, Apple Market, BreadBox, E-Z Mart, fas mart, Li'l Cricket, and Next Door Store. Its retail store offers hot food service, beverages, cigarettes & other tobacco products, candy, salty snacks, grocery, beer, and general merchandise. ARKO operates in three segments: Retail, Wholesale, and GPM Petroleum. The company derives the majority of its revenue from retail and wholesale distribution of fuel.

Read more on ARKO

About BridgeBio Pharma Inc

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.

Read more on BBIO